EUVIMEDEUVIMED entdecken
Crossref

Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian Cancer

Jin Kim, Dong Wook Shin, Jiyoung Lee, Min Ji Lee, Yeon Gyu Yu, Dae-Hee Lee, Tae Hyun Kang iD

ACS Synthetic Biology · 2026

DOI: 10.1021/acssynbio.5c00742 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, 2026. Verfasst von Jin Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Receptors, Lysophosphatidic Acid. Die Arbeit nennt 57 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsReceptors, Lysophosphatidic AcidHumansFemaleAnimalsCell Line, TumorMiceSingle-Chain AntibodiesSignal TransductionMice, NudeProtein EngineeringXenograft Model Antitumor AssaysMice, Inbred BALB C

Stichwörter der Autor:innen

GPCR antibody discoveryP9* expressionamphipathic polymerbiopanninglysophosphatidic acid receptor 2ovarian cancer

Substanzen

Receptors, Lysophosphatidic AcidSingle-Chain Antibodies

Autor:innen und Institutionen

  • Department of Biopharmaceutical Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
  • Antibody Research Institute, Kookmin University, Seoul 02707, Republic of Korea.
  • Department of Wellness-Bio Industry, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea.
  • Biopharmaceutical Chemistry Major School of Applied Chemistry, Kookmin University, Seoul 02707, Republic of Korea.
  • Department of Marine Bio Food and Science, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea.

ORCID-Profile: Tae Hyun Kang

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Kim, J., Shin, D. W., Lee, J., Lee, M. J., Yu, Y. G., Lee, D. H., & Kang, T. H. (2026). Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian Cancer. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.5c00742

Vancouver

Kim J, Shin DW, Lee J, Lee MJ, Yu YG, Lee DH, et al. Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian Cancer. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.5c00742

BibTeX
@article{Kim2026,
  author = {Kim, Jin and Shin, Dong Wook and Lee, Jiyoung and Lee, Min Ji and Yu, Yeon Gyu and Lee, Dae-Hee and Kang, Tae Hyun},
  title = {Engineering Native-like GPCR Antigens Enables Discovery of an LPA2-Blocking Antibody for Ovarian Cancer},
  journal = {ACS Synthetic Biology},
  year = {2026},
  doi = {10.1021/acssynbio.5c00742}
}
Kostenlos starten →